URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l'antihistaminique azélastine afin de lutter contre la COVID-19 This web site uses cookies. By continuing to look through the site you're agreeing to our use of cookies Uncover additional right here ?????